SEC ends probe of ORIC CFO Piscitelli with no enforcement action

Oric Pharmaceuticals, Inc.

CFO Dominic Piscitelli received SEC subpoena in March 2020 re: trading in unrelated companies.
On August 17, 2021, SEC informed Piscitelli investigation concluded without recommending action.
Investigation pertained solely to personal trading of other companies, not ORIC.
Resolution removes potential overhang for CFO and company.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.